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Impaired host response and the presence
of Acinetobacter baumannii in the serum
microbiome of type-II diabetic patients
Dasith Perera,1 Sarah E. Kleinstein,2 Benjamin Hanson,1 Hatice Hasturk,3 Ryan Eveloff,2 Marcelo Freire,2,4,*
and Matthew Ramsey1,5,*
Summary

Type II diabetes (T2D) affects over 10% of the US population and is a growing disease worldwide that manifests with numerous comorbidities and defects in
inflammation. This dysbiotic host response allows for infection of the host by
numerous microorganisms. In the course of T2D disease, individuals can develop
chronic infections including foot ulcers and periodontitis, which lead to further
complications and opportunistic infections in multiple body sites. In this study,
we investigated the serum of healthy subjects and patients with T2D with
(T2DP) or without periodontitis for both microbiome signatures in addition to
cytokine profiles. Surprisingly, we detected the presence of Acinetobacter baumanii in the serum of 23% individuals with T2D/T2DP tested. In T2DP, IL-1b,
TNF-a, MCP-1, IL-6, IL-8, and IFN-g were significantly elevated in ABC-positive
subjects. As an emerging pathogen, A. baumanii infection represents a risk for
impaired inflammation and the development of comorbidities in subjects with
T2D.
Introduction
Type-II diabetes (T2D) is a chronic inflammatory disease affecting 10.5% of the US population, with rising
prevalence both in the United States and worldwide (Whiting et al., 2011; National Diabetes Statistics
Report | Data & Statistics | Diabetes | CDC, 2020). Individuals with T2D typically have numerous comorbidities and are at a greater risk of both opportunistic and nosocomial infections, which can result in significant
morbidity, including amputations, and lost quality of life (QOL) measures (Vardakas et al., 2007; Erben et al.,
2013; McDonald et al., 2014; Ferlita et al., 2019; Kim et al., 2019). Thus, care must be taken to prevent and
monitor the infection status of these individuals, as the development of diabetic mucosal and skin lesions
across the body can impact the host immune and diabetic responses. Key infection prevention includes
minimizing portals of entry and colonization by numerous pathogens. One example of such a portal of entry
is the emergence of diabetic foot ulcers, which can develop diabetic foot infections (DFIs). Roughly 15% of
adults with T2D develop foot ulcers and 14% of these subjects undergo amputation, with the remainder
needing extensive debridement, negative pressure treatments, and other therapies including antibiotics,
which result in prolonged hospitalization time, lengthy healing duration, and increased treatment costs
(Reiber et al., 1998; Driver et al., 2010).
In addition to DFIs, subjects with T2D are 3 times more likely to develop periodontitis (Emrich et al., 1991;
Wu et al., 2020). Periodontitis is an inflammatory oral disease accompanied by a polymicrobial biofilm infection that can lead to tissue damage, chronic lesions, and tooth/bone loss in the oral cavity (Irfan et al., 2001;
Genco et al., 2020; Mann et al., 2020). During periodontal infection, the healthy oral microbiome, especially
in the subgingival space (along teeth below the gumline, including periodontal ligament, epithelium, alveolar bone, and connective tissues), transitions to one enriched with several opportunistic pathogens that
exacerbate inflammation and host tissue damage both locally and systemically (Socransky et al., 1998; Griffen et al., 2012; Hajishengallis and Lamont, 2012; Roberts and Darveau, 2015; Nowicki et al., 2018; Curtis
et al., 2020). Although protective, acute inflammation is a helpful immune response, it is characterized
by rapid activation of inflammation and subsequent return to homeostasis (resolution). Unresolved inflammation that fails to control the trigger leads to chronic lesions and is a hallmark of both periodontitis and
T2D.
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More acute bacteremia can manifest in diseases such as endocarditis or other distal infections by oral microbes (Lockhart and Durack, 1999; Parahitiyawa et al., 2009; Carrizales-Sepúlveda et al., 2018). Various
systemic diseases are in fact influenced by microbial metabolism and host interactions. ‘‘How’’ and
‘‘why’’ immune system imbalance fails to control microbial pathogenic transition remains an active area
of investigation. Increasing evidence implicates periodontal diseases, especially periodontitis in adults,
as a potential risk factor for increased morbidity and mortality from systemic conditions including diabetes,
cardiovascular diseases, adverse pregnancy outcomes, and others (Genco et al., 2020; Kleinstein et al.,
2020b). This is due to two plausible mechanisms: a direct pathway leading to migration of the bacteria
to distal organs and an indirect pathway leading to production of microbial metabolites and/or activating
inflammatory mediators that activate the immune system locally and systemically. This is likely made
possible as periodontitis presents as a chronic inflammatory condition of the tooth-supporting structures
occurring with oral microbiome dysbiosis and continuous inflammatory burden. Notably, oral microbes
have also been detected (Dowd et al., 2008; Gardner et al., 2013) and isolated from DFIs (Bowler and Davies, 1999; Citron et al., 2007). Thus, we hypothesized that patients with T2D might be at a greater risk of
extraoral infection and may exhibit changes in microbiota that transiently occupy their bloodstream. We
further hypothesized that these changes would be even more apparent in patients with T2D with periodontitis (T2DP) and that these patients may carry potential DFI-colonizing oral species in their bloodstream.
Our initial investigations toward these hypotheses utilized samples derived from previous work on resolution of inflammation in T2D (Freire et al., 2017) and are reported here, with unexpected results.
To investigate the possibility of oral species presence in the bloodstream, we compared the serum microbiomes of subjects with T2D and T2DP versus a healthy cohort. Unexpectedly, we detected Acinetobacter
baumanii in 23% of the subjects with T2D/P in our study. A. baumanii is an emerging infectious pathogen
(Villar et al., 2014) notorious for its evolving antibiotic resistances (Gootz and Marra, 2008; Vázquez-López
et al., 2020) and nosocomial (Dijkshoorn et al., 2007; Ayoub Moubareck and Hammoudi Halat, 2020) and
bloodstream infections (Peleg et al., 2008) and is part of a cluster of Acinetobacter species with similar clinical manifestations known as the AB or ABC complex (Gerner-Smidt and Tjernberg, 1993), which are highly
similar via ribotyping. ABC complex organisms present several particular risks to subjects with T2D, specifically higher mortality rates for those with bacteremia (Leão et al., 2016) and for those with higher blood
glucose concentrations (Leung and Liu, 2019). Patients infected with A. baumanii after burns were 9.8 times
more likely to develop glucose intolerance, and 3 times more patients with T2D with burns developed
A. baumanii infections (27%) than patients without T2D (8.5%) (Furniss et al., 2005). Additionally,
A. baumanii has also been observed in DFIs, particularly alongside other multidrug-resistant pathogens,
presenting a grave concern for individuals with T2D (Castellanos et al., 2019; Henig et al., 2020). In addition
to DFIs, ABC complex organisms can also spread through the body and form infections in numerous organs
(Peleg et al., 2008; Al-Anazi and Al-Jasser, 2014). A. baumanii in a mouse pneumonia model led to
increased proinflammatory cytokines, reduced neutrophil infiltration into the lung, and increased extrapulmonary dissemination (Qiu et al., 2009). In T2D, neutrophils present failure in early chemotaxis, but a hyper-inflammatory feedback loop emerges to compensate the initial myeloid cell failure (Kleinstein et al.,
2020a).
In this work, we first investigated whether or not we could detect signatures of oral bacteria; our findings
indicated minor, yet significant, microbiome compositional changes between healthy cohort and patients
with T2D and T2DP. We discovered that nearly one-fourth of the subjects with T2DP in our study contained
sequence reads identical to that of A. baumanii. The specific presence of A. baumanii was confirmed by
further clone library and 16S rDNA Sanger sequencing. In addition, we assayed the host response by cytokine profiles of sera. When stratifying A. baumanii-positive T2D versus A. baumanii-negative T2D samples
we observed unique cytokine profiles, suggesting a specific microbial impact on systemic inflammation.
Although our methodology cannot indicate if A. baumanii was transiently present or a subclinical colonizer
of our T2DP cohort, we propose that these data reveal a much greater risk of currently ‘‘uninfected’’ individuals with T2D for A. baumanii exposure and infection than previously understood and should justify
more intensive and thorough investigation into AB complex colonization of patients with T2D.

Results
Patient demographics
Serum samples were generated from the population described in Table 1. A total of 81 subjects were investigated in this study, 57 with T2D, of which 29 had periodontitis (T2DP) as defined by the American
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Table 1. Study subject demographics

Healthy
(N = 24)

Type II
diabetes
(N = 57)

Total
(N = 81)

p value

46 G 10.72

55 G 10.78

52.78 G 11.40

<0.001

Male

13 (54%)

29 (51%)

42 (51.85%)

Female

11 (46%)

28 (49%)

39 (48.15)

Caucasian

15 (63%)

25 (43.86%)

40 (49.38%)

Hispanic

2 (8%)

7 (12.28%)

9 (11.11%)

African American

6 (25%)

23 (40.35%)

29 (35.80%)

Asian

0

2 (3.51%)

2 (2.47%)

Other

1 (4%)

0

1 (1.23%)

Smokers

1 (4%)

5 (8.77%)

6 (7.41%)

Former smokers

0

21 (36.84%)

21 (25.93%)

Never smokers

23 (96%)

31 (54.39%)

54 (66.67%)

BMI (kg/m2; mean G SD)

29.34 G 2.60

32.93 G 6.02

31.87 G 5.48

<0.01

Blood cholesterol (mg/dL; mean G SD)

148.89 G 36.71

211.73 G 78.69

194.01 G 74.84

<0.001

HbA1c (%; mean G SD)

–

7.48 G 1.61

–

–

Blood Glucose (mg/dL; mean G SD)

99.25 G 19.29

190.84 G 60.58

163.70 G 66.69

<0.0001

Age (mean in years GSD)
Gender (no., %)

0.45

Ethnicity

0.16

Smoking status (no., %)

0.02

Periodontal condition (no., %)
Healthy

24 (100%)

7 (12.28%)

31 (38.27%)

Mild

0

15 (26.32%)

15 (18.52%)

Moderate

0

11 (19.30%)

11 (13.58%)

Severe

0

12 (21.05%)

12 (14.81%)

Gingivitis

0

10 (17.54%)

10 (12.35%)

Stable periodontitis

0

2 (3.51%)

2 (2.47%)

Positive

0

13 (22.81%)

13 (16.05%)

Negative

19 (79%)

29 (50.88%)

48 (59.26%)

Not tested

5 (21%)

15 (26.32%)

20 (24.69%)

Neutrophil count (million cells, mean G SD)

74.82 G 58.56

158.22 G 90.08

131.90 G 94.51

<0.0001

Monocyte count (million cells, mean G SD)

63.79 G 50.35

113.91 G 60.09

99.22 G 63.28

<0.01

<0.0001

ABC positive (no., %)

0.02

p values calculated by unpaired t tests or c2 (two-sided p values; italicized p < 0.05 significant).
BMI, body-mass index; ABC, A. baumanii; %, percentage; mg/dL, milligrams per deciliter; kg/m2, kilograms per square meter.
Smoking classification according to CDC National Health Interview Survey (NHIS).

Association of Diabetes (American Diabetes Association, 2015) and American Association of Periodontology (AAP) (Armitage, 1999) criteria, respectively. All T2D donors were poorly controlled diabetic subjects
who had not taken antimicrobials, non-steroidal anti-inflammatory drugs, or insulin sensitizers within three
months. Diagnostic serum glucose measures were taken for all subjects, and HbA1C was measured for diabetic patients to stage disease status. As expected, poorly controlled diabetic subjects (HbA1c% >6.5%)
showed significantly elevated glucose levels (p < 0.0001; Table 1). There were no significant differences
in gender or ethnicity between healthy volunteers and diabetic patients. Diabetic patients showed
elevated body mass index and tended to be older than healthy controls (p < 0.05), consistent with known
disease biology. Periodontal condition was further stratified among the subjects according to the severity
of irreversible tissue loss (mild, moderate, severe) and reversible lesions called gingivitis according to AAP
(Armitage, 1999) criteria. Periodontal condition was significantly worse in diabetic compared with healthy
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subjects (p < 0.0001). All healthy subjects had healthy periodontal condition compared with only 11% diabetic patients, with 15% diabetic subjects suffering from severe periodontitis. Current and former smokers
were near uniformly part of the T2D and T2DP groups with only one current smoker in the healthy group.
The entire study population had a median age range of 53 G 11 years, and all subjects were outpatient and
thus not part of an extended hospital stay cohort.

Microbiome analysis controls for low template sequencing
Data generated here was part of a post hoc study of serum samples collected for a previous study (Freire
et al., 2017) and thus not available in the larger volumes ideal for 16S microbiome dataset generation. Low
template concentrations can produce microbiome signatures not derived from that in the biological samples due to amplification of contaminating genomic DNA (gDNA) in sterile buffers and reagents (Kennedy
et al., 2014; Salter et al., 2014; Kim et al., 2017), which often manifests as aquatic species signatures, many of
which are not compatible with growth in the human host (i.e., many do not even grow at 37 C) (Kim et al.,
2017). A description of no-template/reagent-only control samples is provided in the Methods. Data within
this study are provided as either minimally filtered (mitochondrial, human, and chloroplast aligned reads
removed) or strict filtered (reads removed based on homology with reagent-only controls) and indicated
as such throughout the study. All sequence data are made available at NIH SRA Bioproject PRJNA664044,
and all scripts used for data generation, filtering, and analyses are provided in the Supplemental
Information.
We were able to generate abundant data from these samples with careful consideration paid to controls for
amplification bias and background bacterial gDNA contamination of commercial sterile reagents. First, we
utilized amplification of a mock standard library of 8 bacterial and 2 fungal species (Figures S1A and S1B) at
10 and 1 ng of total template, which indicated that our library preparation protocol was suitable for specieslevel analysis where possible by V1-V3 sequence. Second, we utilized 13 separate no-template/reagentonly controls, which were subjected to our sequence analysis pipeline, revealing frequently encountered
contaminating taxa. These taxa were filtered from each human-derived sample in the strict-filtered datasets only.

V1-V3 16S microbiome diversity analyses reveal minor but significant differences between
diabetic and nondiabetic groups
Serum and control samples were subject to bead beater lysis and gDNA purification. Purified gDNA was
amplified using the V1-V3-targeted 27F-519R primer pair (Stackebrandt and Goodfellow, 1991; Turner
et al., 1999). Quality trimmed reads were subjected to DADA2 analysis (Callahan et al., 2016) and aligned
to the SILVA database (Quast et al., 2013) to determine species-level identity where possible. Rarefaction
curve analysis was performed to ensure adequate sequencing depth (Figure S2), and resequencing of each
Illumina index was performed to generate greater sequencing depth without further template amplification. Run-to-run variability between next-generation sequencing was found to be insignificant (Figure S3).
Data analysis and comparisons were performed via QIIME2 (Bolyen et al., 2019) as detailed in the Methods.
We first quantified alpha and beta diversity between the healthy, T2D, and T2DP subject groups for our
strict filtered (Figures 1and S7) and minimally filtered data (Figure S4). For both datasets, species richness
for T2D and T2DP groups were significantly different than the healthy cohort, which was also significantly
different when compared with T2DP in each dataset for species evenness (T2D more rich, T2DP less rich,
and less even). Beta diversity was significantly less for healthy subjects versus T2D and greater when
compared with T2DP for either minimal or strict filtered datasets. Thus, we observed minor but significant
shifts in microbiome composition between subject groups.
To begin investigating which taxa contributed to this composition difference we first looked at a phylumlevel display of our taxonomically assigned data (Figure 2). Figures 2A and 2B, respectively, indicate
phylum-level data for strict versus minimal filtered datasets. Similar trends in phyla distribution were
evident for either dataset and reveal minor phylum-level changes between subject groups.

MED and DADA2 analysis reveal the presence of Acinetobacter baumanii
Given our initial investigation into whether or not there were differences between T2D and T2DP microbiota and a preliminary hypothesis that oral taxa would be enriched in T2DP serum, we first used a minimal
entropy decomposition (MED) analysis identical to the one used previously to characterize oral
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C

Figure 1. 16S alpha and beta diversity of serum microbiomes changes with subject status
(A–C) Species richness is displayed based on Faith’s phylogenetic diversity (Faith, 1992) (A), and species evenness is
based on Pielou’s evenness index (Pielou, 1966) (B) for healthy, type-II diabetic patients (T2D), and type-II diabetic
patients with periodontitis (T2DP) samples. Significance was determined by Kruskal-Wallis analysis of variance (Kruskal
and Wallis, 1952) for each comparison indicated, and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995)
was applied to generate adjusted q-values. All data used were strictly filtered based on no-template control indexes. *qvalue < 0.002 compared with healthy, **q-value < 0.0004 compared with healthy and with T2D. (C) Beta diversity BrayCurtis distances. Pairwise PERMANOVA of each category versus each (group size of 3, n = 112) was performed in 999
permutations. ***q-value differs from ‘‘healthy’’ < 0.001. See also Figure S4.

microbiomes (Eren et al., 2014). Oligotyped ‘‘nodes’’ or representative sequences were aligned to both the
Human Oral Microbiome (HOMD) (Escapa et al., 2018) and Ribosomal Database Project (RDP) (Cole et al.,
2014) databases, and species were assigned based on 98% or higher sequence identity when comparing
nodes to reference databases. We next compared species-assigned data between subject groups by linear
discriminate analysis effect size measurements (LEfSe) (Segata et al., 2011). Using MED-analyzed data for
healthy versus all subjects with T2D (Figure 3) we detected significant enrichments of some oral species
(Streptococcus cristatus, Neisseria flavescens) and also some known reagent contaminants (Ralstonia picketti, Afipia broomeae) alongside other soil and freshwater microbes that we suspect are also contaminants
(Flectobacillus, Stenotrophomonas, Sphingobium, Arthrobacter). Surprisingly, we observed A. baumanii
significantly enriched in the T2D population as a whole. For MED analysis, reads assigned as
A. baumanii were present from 0.01% to 7.3% of total reads in 8 and 5 subjects with T2D and T2DP, respectively. No reads assigned to A. baumanii were detected in any healthy subject. DADA2 amplicon sequence
variants (ASVs) are similar to MED nodes, and we observed that one ASV node was a perfect match to the
singular MED node assigned to A. baumanii based on 100% RDP alignment across its full sequence.
In our DADA2/QIIME2-based analysis we performed taxonomical assignment for each DADA2 ASV node
aligned to either the Greenegenes (DeSantis et al., 2006) (not shown) or SILVA database version 132 (Quast
et al., 2013). Phylum-level taxonomic assignments of DADA2 data aligned to SILVA were used in Figure 2.
ASVs are similar to MED nodes, and we observed that one ASV node was a perfect match to the singular
MED node assigned to A. baumanii based on 100% RDP alignment across its full sequence. This ASV was
assigned only to the Acinetobacter genus despite a 100% full-length match to A. baumanii sequence at the
RDP database and the NCBI non-redundant database (not shown). Based on this, we manually assigned
this ASV to A. baumanii and found that reads now assigned to A. baumanii were present from 0.01% to
9.1% of total reads in 8 and 5 subjects with T2D and T2DP, respectively, with no reads assigned to
A. baumanii detected in any healthy subjects. This demonstrated agreement between both MED and
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Figure 2. Phylum-level diversity changes between subject status
(A and B) DADA2-analyzed data were aligned to the SILVA database for taxonomical assignment via QIIME2 as described
in Methods. Data from both sequencing runs were collapsed to phylum-level taxa and displayed for (A) strict filtered and
(B) minimally filtered conditions. Asterisks on the top indicate run-run sample pairs that were positive for A. baumanii.

DADA2-based 16S data analysis. LEfSe analysis was again performed on healthy subjects versus all with
T2D, as well as between all three subject groups, and demonstrated again that A. baumanii was significantly elevated among all T2D samples (Figure S5).
We next looked at differences in microbiome compositions across subjects by plotting Bray-Curtis
distances via non-metric multidimensional scaling (NMDS) while distinguishing subject groups as well as
presence or absence of ABC bacteria (Figure 4). Broadly, T2D and T2DP samples had less overlap in
composition, whereas healthy samples intersected either group. ABC status did not seem to form a distinct
microbiome cluster, suggesting that there was no unique microbiota composition for ABC-positive subjects apart from A. baumanii sequence detection.

Validating the presence of A. baumanii in subjects with T2D
The finding of ABC sequences was unexpected, as study participants were not hospitalized or under treatment for any infection(s), and we wished to confirm this result by other techniques. This was especially
needed as the V1-V3 portion of the 16S rDNA sequence only differs between A. baumanii and Acinetobacter nosocomialis by one nucleotide substitution. Using PCR primers for the 16S rDNA region that encompasses nearly all differentiating 16S nucleotides between Acinetobacter species we generated amplicons from a portion of our ABC-positive samples alongside negative healthy and no-template control
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Figure 3. Healthy subjects versus all subjects with T2D reveal a potential enrichment of A. baumanii
Initial minimal entropy decomposition (MED) analysis of 16S data with taxonomy assigned based on RDP database
alignment to generate species-level assignments was performed followed by linear discriminate analysis effect size
quantification (LEfSe). This revealed enrichment of several species/genera in subjects with T2D relative to healthy. DADA2
analysis of the same dataset was aligned to the SILVA database and shows similar patterns of enrichment (see also
Figure S5).

samples (Figure 5). PCR products were ligated into a TA vector, and individual colonies were propagated
and subjected to Sanger sequencing of plasmid inserts. The 1242-bp sequences were then aligned to the
NCBI reference RNA sequence database (refseq_rna). Each sequence (12 clones across 5 samples) was
identical and matched the A. baumanii 16S sequence across its length. This result validated our initial
16S detection of putative A. baumanii.

Host cytokine responses to T2D and T2DP versus health
In addition to serum microbiota, we also quantified 20 different human cytokines in serum samples across
all 3 patient groups (Figure 6). Based on relative abundance profiles, we observed that proinflammatory
cytokines were significantly elevated in A. baumannii-positive samples highlighted in the box (ABC+).
MCP-1 and IL-1b, classic proinflammatory cytokines, were increased in diabetic patients. Intriguingly,
T2D ABC-negative subjects did not show increase of these markers. ABC+ subjects showed significantly
higher expression levels of cytokines IL-1b, IL-6, IL-8, MCP-1, and IFN- g when compared with ABC-negative groups (I and V, p < 0.01).

Host cytokine responses to specific microbiota
Based on the cytokine abundance data and earlier microbiome sequencing, we were able to determine if
any specific taxa were significantly correlated with cytokine presence or absence in subjects with T2D
(Figure 7). A. baumanii was significantly correlated with elevated amounts of IFN-a, IFN-g, IL-12p70, IL-8,
and TNF-a. ABC+ subjects presented cytokine correlations consistent with a profile of chronic inflammation. IL-8 is a chemokine that impacts neutrophil phenotype and function, and excessive amounts of this
cytokine lead to chronic activation of phagocytes (Moore and Kunkel, 2019). Excessive production of
TNF-a increases failure of resolution of inflammation on innate immune cells by controlling a resolution
receptor (Freire and Van Dyke, 2013). Here, TNF-a showed a significant increase in ABC+ subjects, suggesting co-existence with ABC in the serum of patients with T2D. We also performed an identical analysis for
healthy subjects and saw several genera or species with significant correlations (Figure S6). In healthy subjects unique profiles were found, correlated with lower levels of proinflammatory cytokines and co-clustered with ABC-negative samples.
Although low template concentration microbiome profiling presents many challenges, we were able to utilize numerous control steps to minimize the impact of contaminating taxa. We were also able to demonstrate that there were significant differences between subject groups that include taxa of likely biological
origins, and also that specific cytokines significantly correlated with the presence of distinct taxa. Most surprisingly, we were able to detect A. baumanii and confirm its presence in serum samples of patients with
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Figure 4. Beta diversity quantification between subject groups
(A and B) SILVA-assigned taxonomy of DADA2-analyzed 16S data was used to determine Bray-Curtis dissimilarity
between samples for strictly filtered (A) and minimally filtered (B) data. Non-metric multidimensional scaling and
statistical analysis for each subject group was performed in R using the vegan package as described in Methods. p-value
of 0.001 determined by PERMANOVA test via the adonis2 function.

T2D not known or currently diagnosed with any underlying infection. These data do not per se indicate
active infection but could also indicate colonization or transient exposure to A. baumanii for these subjects
compared with healthy subjects.

Discussion
Issues with amplification-based 16S studies from low template concentrations are well known (Sinha et al., 2015;
Kim et al., 2017; Pollock et al., 2018). We began this study as a post hoc analysis of existing serum samples from a
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Figure 5. Clone library design to verify ABC complex member identity
Amplification with oMR328-329 primers produced an amplicon between 120 and 1306 bp of the A. baumanii 16S rDNA
sequence. This allowed for Sanger sequencing of information-rich nucleotides indicated above allowing for species
differentiation beyond initial V1-V3 sequencing with the 27F-519R primers. The table beneath indicated the total number
of individual clones sequenced per sample and which species they aligned to with 100% identity in the NCBI nonredundant database.

previous bank of anonymized specimens (Freire et al., 2017). As sample volumes of serum were mostly limited,
we relied on amplification of 16S rDNA, using V1-V3 region primers to improve the likelihood of identifying oral
taxa (Eren et al., 2014) that we hypothesized to exist in the diabetic with periodontitis part of our cohort. To minimize effects of amplification, we performed multiple high-throughput sequencing runs of amplified libraries to
increase sequence depth as opposed to further amplification and using a higher capacity sequencing platform.
Additionally, we also included numerous no-template controls throughout sample preparation and purification
to identify as many outside contaminants as we could (Kennedy et al., 2014; Salter et al., 2014; Kim et al., 2017). As
a further control, we carried out amplification of mock community libraries (Figure S1) to determine if amplification bias or infidelity affected taxonomic assignment. We also used two separate methods for correction of Illumina-sequenced amplicon errors, DADA2 (Callahan et al., 2016) and minimal entropy decomposition/oligotyping (MED) (Eren et al., 2015), as well as comparing our data from multiple ribosomal databases for taxonomic
assignment (DeSantis et al., 2006; Quast et al., 2013; Cole et al., 2014). In addition to Illumina sequencing, we
performed a separate amplification of 16S rDNA followed by Sanger sequencing to independently confirm
the identity of putative A. baumanii sequence presence in a subset of our diabetic samples (Figure 5). Thus,
we have made great efforts to validate our findings as far as is feasible and have taken care not to overinterpret
data presented here.
We initially hypothesized that oral taxa would be enriched in the bloodstream of subjects with T2DP, and
potentially all subjects with T2D, compared with healthy subjects. Our microbiome data revealed changes
in composition between our three subject groups (Figures 1, 2, 3, 4, S4, and S5). However, there was only
enrichment of few oral taxa when healthy subjects were compared with all subjects with T2D and not with
subjects with T2DP alone, specifically S. cristatus and N. flavescens (Figure 3), which are not associated with
periodontitis. Their presence here could indicate further access to the bloodstream by oral microbes in the
T2D cohort, although this requires further verification. Given the limited template available for each sample, we cannot rule out that other oral taxa are not elevated in subjects with T2D/P, but more rigorous
testing of that hypothesis would require larger serum volumes and using a longitudinal approach. By far
the most surprising element of this dataset was the detection of A. baumanii- (Figures 3 and S5) assigned
reads unique to 13 subjects with T2DP and not present in any control or healthy subject samples.
A. baumanii represents a considerable risk to subjects with T2D including higher mortality rates (Leão et al., 2016)
and a higher risk of infection in burn wounds, as well as DFIs (Furniss et al., 2005; Castellanos et al., 2019; Henig
et al., 2020). To confirm our V1-V3 amplicon data and to determine whether or not these were A. baumanii or
another ABC species, we used targeted near-full-length 16S rDNA primers that allowed us to sequence the majority of differentiating nucleotides necessary for ribotyping. Sequencing individual clones of these amplicons
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Figure 6. Cytokine profile quantification reveals distinct differences between subject groupings and A. baumanii
(ABC) presence
Heatmap showing immune mediator concentrations derived from serum of diabetic and healthy samples were compared
to understand the role of ABC in each sample group. (I) Diabetic/Healthy, (II) All ABC+/All ABC-, (III) ABC+ Diabetic/ABCDiabetic, (IV) ABC+ Diabetic/Healthy, (V) ABC- Diabetic/Healthy. Data are clustered according to comparison groups
(red, highest expression; yellow, lowest expression). Hierarchical clustering was employed by Morpheus from the Broad
Institute (Morpheus, https://software.broadinstitute.org/morpheus). Observations from hierarchical clustering are shown
in a tree, with ABC groups highlighted in the box. ABC+ groups (II, III, and IV) showed significantly different (p < 0.01)
levels of IL-1b, IL-6, IL-8, MCP-1, IFN- g. *p value <0.01 between groups via unpaired Student’s t test (red, highest
expression; yellow, lowest expression).

revealed 100% matches to A. baumanii, and no clones (n = 50) were A. baumanii positive from indicated control
samples (Figure 5). This result was surprising, as none of the subjects in our T2D/P cohort were currently under
inpatient treatment or had any indication of underlying infection (apart from periodontitis). Given the methodology here, neither can we speculate on the true infection status of these individuals nor can we be certain if the
A. baumanii present were circulating in the bloodstream or were on the skin and mixed with the sample during a
blood draw. No matter the route of entry, we were able to determine significant cytokine profile changes in T2DP
A. baumanii-positive subjects, as well as broader inflammatory changes in cytokine profiles between subjects
with T2DP and T2D and healthy subjects (Figure 6).
Cytokine dysregulation can impact the host locally and systemically, making the subject more prone to
severe infections and increased tissue damage (Tisoncik et al., 2012). Individuals who have T2D present
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Figure 7. Host-microbial correlation-resolved type-II diabetic associations with inflammatory cytokines
HOMD/RDP assigned taxonomy of MED-analyzed 16S data for both T2D and T2DP samples and cytokine concentrations
were analyzed via Pearson correlation coefficient in R using the rcorr function. Significance was determined using the
asymptotic p values generated by rcorr with *p value <0.05, **p value <0.01. Data are strictly filtered with taxa present in
no-template controls subtracted. See also Figures S6, S8, and S9.

an increased metabolic burden, while often comorbid periodontal disease promotes microbial dysbiosis,
with both diseases resulting in a chronic state of inflammation. In the present study, A. baumanii was only
found in the serum of diabetic subjects, where an increase in proinflammatory cytokines was also
observed (Figures 6 and 7). We utilized an unbiased panel of 20 human cytokines to survey specific immune responses to T2D and T2DP compared with those of healthy individuals. Although there are complications presented by low template sizes in our samples, cytokine profiling from these same volumes
were well within desired assay volumes. As mediators of inflammation, cytokine production feeds forward
a cascade of signals that can impact tissue, organ, and overall host immunometabolism. In T2D, IL-1b,
TNF-a, MCP-1, IL-6, IL-8, and IFN-g were significantly elevated in ABC+ subjects and not in ABC-negative
subjects. Of these proinflammatory cytokines, IL-1b, TNF-a, and IL-8 suppression has been investigated
as therapeutic targets for clinical management of diabetes and associated chronic lesions (Peiró et al.,
2017; Feng et al., 2018). We previously observed increased TNF-a levels in cell cultured neutrophils
from subjects with T2D relative to cells derived from healthy subjects (Kleinstein et al., 2020a). Co-occurrence of bacteria in the serum and cytokines also differed among controls. In the current study, co-occurrence among cytokines was more evident in diabetic subjects (100 significant co-occurrences) versus
healthy individuals (30 significant co-occurrences) (Figures 7 and S6). A baumannii especially correlated
with neutrophil inflammatory signaling cytokine IL-8, which was not observed in healthy subjects. We
have previously shown differences in gene expression in neutrophils of individuals with T2D, which are
primed to mount an aberrant inflammatory response when compared with neutrophils of healthy individuals (Kleinstein et al., 2020a), consistent with production of inflammatory cytokines observed here. In
contrast, IL-17a, P-selectin, and E-selectin levels were increased in diabetic subjects who were ABC-negative compared with ABC+ diabetic subjects. IL-4 and IL-10 did not co-occur with A. baumanii in any of the
healthy versus diabetic groups. The cytokine results provide an initial glimpse into the host response to
chronic inflammatory diseases, T2DP with and without the presence of A. baumannii, which may warrant
further investigation in larger studies.
In conclusion, this study has revealed modest serum microbiome compositional changes and significant cytokine profile changes between subjects with T2D with or without periodontitis versus nonT2D individuals, revealing an impaired host response when A. baumanii was present. We also present
here the potential for lurking A. baumanii colonization in asymptomatic subjects with T2D, possibly to
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a much larger extent than previously reported. In our opinion, these data present a strong justification
for further monitoring of individuals with T2D for A. baumanii colonization and support the need for a
more robust study to characterize the potentially greater spread of A. baumanii among individuals
with T2D.

Limitations of the study
Limitations of this study primarily include small template volumes available for serum samples in this post
hoc study. Blood and sera microbiome studies will always be more complex due to low bacterial template concentrations inherent to these types of sample. Although we have made utmost efforts to validate our main findings regarding A. baumanii presence, there are likely more interesting aspects to our
study cohort microbiota that have been missed. These and other minor limitations have been indicated
in the article.

Resource availability
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Figure S1. Mock library composition evaluation. Related to Figure 1. A Zymogen mock
community library was used for sequence library construction at 10 and 1 ng in duplicate
between both sequencing runs. QIIME2 / DADA2 unfiltered data was given taxonomical
assignment via SILVA and assessed via the “q2-quality-control” plugin. (A) Taxon accuracy rate
(TAR), taxon detection rate (TDR) and linear regression scores (r-squared) are plotted at each
taxonomic level. (B) Expected vs observed abundance of each species in the mock community
is plotted at each taxonomic level. (C) Distance between false positive observations vs nearest
expected feature. Misclassifications were unique to environmental contaminant taxa and no
false negative features were observed (not shown).
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Figure S2. Alpha-diversity at different rarefaction levels. Related to Figure 1. Total observed
OTUs (here ASVs) are plotted (A) vs sequencing depth and each sample that can
accommodate that sequencing depth is plotted in (B).
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Figure S3. Run to Run variability quantification. Related to Figure 1. A Run vs Run Beta
diversity comparison was performed for unfiltered data by comparing unweighted Unifrac
distances as described in the methods. Pairwise PERMANOVA of Run-1 vs Run-2 (group size
of 2, sample size of n=134 total indexes) was performed in 999 permutations resulting in a
pseudo-F value of 0.567, p-value of 0.999 and corrected q-value of 0.999. No significant
differences were observed between each run.
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Figure S4. 16S Alpha and Beta diversity of serum microbiomes changes with subject
status. Related to Figure 1. Species richness is displayed based on Faith’s phylogenetic
diversity (Faith, 1992) (A) and species evenness based on Pielou’s evenness index (Pielou,
1966) (B) for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis (T2DP)
samples. Each graph used minimally filtered data for analysis. Significance was determined by
Kruskal-Wallis analysis of variance (Kruskal and Wallis, 1952) for each comparison indicated
and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995) was applied to generate
adjusted q-values. * indicates q-value < 2e-3 vs healthy, ** indicates q-value < 0.024 vs
healthy, (C) Beta-diversity Bray Curtis distances. Pairwise PERMANOVA of each category vs
each (group size of 3, n=112) was performed in 999 permutations. *** indicates q-value differs
from healthy < 0.001.
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Figure S5. LEfSe Comparisons reveal taxonomical differences between subject groups.
Related to Figure 3. (A) LEfSe Cladogram plots (Segata et al., 2011) reveal general taxonomic
shifts compared to (B) specifically enriched genera or species in all diabetics vs healthy and (C)
compared across all 3 subject groups. Data was generated from DADA2 / QIIME2 analyzed
data aligned to the SILVA database that was then filtered for contaminating taxa abundant in
no-template control indexes. Pseudomonas genus / species level results were also removed for
clarity.
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Figure S6. Cytokine correlation with specific taxa in healthy subjects. Related to Figure 7.
HOMD/RDP assigned taxonomy of MED analyzed 16S data for healthy samples and cytokine
concentrations were analyzed via Pearson correlation coefficient in R using the rcorr function.
Significance was determined using the asymptotic p-values generated by rcorr with * = p-value
<0.05 ** = p-value <0.01. Data are strictly filtered with taxa present in no-template controls
subtracted.
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Figure S7. 16S Alpha and Beta diversity of serum microbiomes changes with subject
status. Related to Figure 1. Alpha diversity is displayed based on Shannon’s index (Shannon
and Weaver, 1975) (A) and species evenness based on Simpson’s evenness measure
(Simpson, 1949) ) (B) for healthy, type-II diabetic (T2D) and type-II diabetics with periodontitis
(T2DP) samples. Each graph used minimally filtered data for analysis. Significance was
determined by Kruskal-Wallis analysis of variance (Kruskal and Wallis, 1952) for each
comparison indicated and Benjamini-Hochberg correction (Benjamini and Hochberg, 1995) was
applied to generate adjusted q-values. * indicates q-value < 1e-5, ** indicates q-value < 0.007,
(C) Beta-diversity unweighted Unifrac distances. Pairwise PERMANOVA of each category vs
each (group size of 3, n=112) was performed in 999 permutations. *** indicates q-value differs
from ‘healthy’ < 0.02.
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Figure S8. Host-microbial correlation resolved type-II diabetic associations with
inflammatory cytokines. Related to Figure 7. SILVA assigned taxonomy of DADA2 analyzed
16S data for both T2D and T2DP samples and cytokine concentrations were analyzed via
Pearson correlation coefficient in R using the rcorr function. Significance was determined using
the asymptotic p-values generated by rcorr with * = p-value <0.05 ** = p-value <0.01. Data are
strictly filtered with taxa present in no-template controls subtracted.
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Figure S9. Cytokine correlation with specific taxa in healthy subjects. Related to Figure 7.
SILVA assigned taxonomy of DADA2 analyzed 16S data for healthy samples and cytokine
concentrations were analyzed via Pearson correlation coefficient in R using the rcorr function.
Significance was determined using the asymptotic p-values generated by rcorr with * = p-value
<0.05 ** = p-value <0.01. Data are strictly filtered with taxa present in no-template controls
subtracted.
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Transparent Methods
Subject recruitment, sampling and storage
Subject recruitment has been described previously (Freire et al., 2017). Peripheral venous blood
(∼60 ml) was collected from patients diagnosed with T2D and from healthy nondiabetic controls.
Blood samples were collected and centrifuged at 2300 rpm, and serum was isolated and frozen
at -80°C until analysis under IRB protocol #13-07. All subjects gave signed informed consent
prior to study evaluations. Clinical periodontal data and peripheral venous blood were collected.
The diagnosis of T2D was made by the subject’s primary care physician following American
Association of Diabetes guidelines (American Diabetes Association, 2015). Information was
collected on subject demographics (age, gender, self-reported ethnicity, and self-reported
smoking status), body-mass index (BMI; kg/m2), blood total cholesterol, blood glucose (point-ofcare), percent hemoglobin A1C (HbA1c), and periodontal condition (Armitage, 1999). HbA1c
was used to determine the level of glycemic control for diabetic subjects. One T2D individual
lacked HbA1c measurements but fit based on all other diagnostic criteria (blood glucose >200
mg/dl) as well as cytokine profiles in accord with other T2D individuals. Neutrophil and
monocyte cell counts were determined by lab assay (described below). Individuals were
excluded if they were taking insulin sensitizers, nonsteroidal anti-inflammatory drugs, or
antimicrobials within 3 months of study initiation. Smoking status was defined by CDC NHIS
terms
(https://www.cdc.gov/nchs/nhis/tobacco/tobacco_glossary.htm#:~:text=Former%20smoker%3A
%20An%20adult%20who,in%20his%20or%20her%20lifetime). Site collection before blood
draw: Samples were drawn in clinical phlebotomy settings. From all serum sampled for this
microbiome study, a total of 81 subjects (N=24 healthy, N=57 T2D) were included for analysis,
all of whom were unrelated and over 18 years of age (range: 28-79 years of age).
Sample preparation for 16S analysis
DNA Extraction
Frozen serum from N=81 samples (N=24 healthy, N=32 T2D and N=25 T2DP) were thawed on
ice and aliquots were separated for DNA extraction. DNA was extracted using the Epicentre
MasterPure Complete DNA and RNA Purification kit (Lucigen, WI, USA). Extraction was carried
out using the manufacturer’s instructions, with modifications that enabled bead beating. Briefly,
200µL of Tissue and Cell Lysis Solution (2x), 100µL of nuclease free water and 2µL of
Proteinase K were added to Lysing matrix B (LMB) tubes (MP Biomedicals, Santa Ana, CA).
Thereafter 100µL of serum was added to the tubes and placed in a Beadbeater (Biospec) for 30
seconds, then placed on ice for 3 minutes and then repeated. Each round of DNA extractions
included a no template control, which consisted of 100µL nuclease free water instead of serum.
The samples were then incubated and extracted as described in the manufacturer’s instructions.
Total DNA was precipitated using the manufacturer’s instructions, however 300 µL of MPC
Protein Precipitation Reagent was used to accommodate the increased volume. DNA was
eluted in 50µL of nuclease free water.
16s rDNA primers 27F
(TCGTCGGCAGCGTCAGATGTGTATAAGAGACAGAGAGTTTGATYMTGGCTCAG) and 519R
(GTCTCGTGGGCTCGGAGATGTGTATAAGAGACAGGWATTACCGCGGCKGCTG)
(Stackebrandt and Goodfellow, 1991; Turner et al., 1999) were used to amplify the V1-V3
regions of 16s rDNA in a 50 µL reaction using 2x Q5 HiFi mastermix (New England Biolabs,
Ipswitch, MA) and 23 µL of extracted DNA (35 cycles).
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Illumina MiSeq Library preparation
After the first round of PCR was carried out it was cleaned with Ampure XP beads (Beckman
Coulter, Pasadena, CA) and then visualized by agarose gel electrophoresis. Full indices and
adapters were added using the Illumina Nextera Index Kit (Illumina, San Diego, CA) by running
the second round of PCR (50 ng of template DNA, 5 cycles) in 2x Phusion HF Master Mix (New
England Biolabs, Ipswitch, MA). PCR were then cleaned with Ampure XP beads and analyzed
by agarose gel electrophoresis and using the Agilent BioAnalyzer DNA1000 chip (Agilent
Technologies, Santa Clara, CA). Samples were then quantified and normalized prior to pooling
using a Qubit fluorimeter (Invitrogen, Carlsbad, CA). The final pooled library was quantified with
the KAPA Biosystems Illumina Kit (KAPA Biosystems, Woburn, MA) via qPCR in a Roche
LightCycler480. Samples were sequenced (2x250 bp paired-end) on an Illumina MiSeq
(Illumina, San Diego, CA) at the Rhode Island Genomics and Sequencing Center (Kingston, RI).
Mock Community Standards Preparation
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In order to quantify potential bias due to low template concentrations, PCR amplification, and
contamination, we performed mock library assemblies with commercially available bacterial
genomic DNA templates (Zymo Research #D6305). We amplified 2 libraries using 10 and 1 ng
total starting templates in both sequencing runs for a total of 4 mock libraries synthesized.Total
DNA species composition is provided in the manufacturer’s instructions.
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16S clone library resequencing
Primers were made to amplify regions of 16s rDNA that enable differentiation of the
Acinetobacter species. Primers used were
oMR328 (TAGCGGCGGACGGGTGAGTAATGCTTA) and
oMR329 (TTCCGACTTCATGGAGTCGAGTTGCAGAC). 50 µL reactions in 2x Q5 mastermix
(New England Biolabs, Ipswitch, MA) were run for 35 cycles using 23 µL of DNA extracted from
serum as the template. The products were then purified using the Qiagen PCR purification kit
according to the manufacturer’s instructions. Gotaq 2x mastermix (Promega, Madison, WI) was
used to generate ‘A’ overhangs via PCR for 5 cycles using 10 µL of purified DNA as the
template. 4µL of the resulting PCR products were then used to generate clones using the TOPO
TA Cloning Kit (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions which
was modified to use 0.5µL of TOPO vector. Clones were then transformed into NEB5α cells
using the manufacturer’s instructions and plated on LB plates supplemented with 0.1mM IPTG
and 40µg/mL Kanamycin. Additionally, 40µl of 40mg/mL of X-gal was spread onto each plate
prior to plating to enable blue-white screening. The plates were incubated for 24 hours at 37°C.
White colonies were inoculated into liquid cultures of LB supplemented with 40µg/mL
kanamycin. Plasmids were extracted using QIAprep Spin Miniprep kit (Qiagen, Venlo,
Netherlands). Inserts were sequenced using the M13 Forward (GTAAAACGACGGCCAGTG)
and M13 Reverse (CACAGGAAACAGCTATGACC) primers on an Applied Biosystems 3500xl
using the “BigDye” Terminator v3.1 Cycle sequencing kit. Sequences were analyzed using
NCBI BLAST (NCBI Resource Coordinators, 2018). A maximum of 10 colonies were screened
for each sample or until a sequence matched a species belonging to the Acinetobacter
baumanii- calcoaceticus complex.
Cytokine Quantification
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Frozen (-80°C) subject serum was brought up to room temperature and assayed using the
Invitrogen human inflammation 20-plex ProcartaPlex cytokine panel (Thermo Fisher Scientific,
Waltham, MA) on a Luminex 200 instrument (Luminex, Austin, TX) in universal assay buffer.
Assayed cytokines included: MIP-1α, IL-1β, IL-4, IP-10, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL17A, IFN-γ, GM-CSF, TNF-α, MIP-1β, IFN-α, MCP-1, P-Selectin, IL-1α, sICAM-1, and ESelectin. Following manufacturer protocols, all samples were run on a plate with 7 standards
(diluted 1:4) and a control (universal assay buffer only), with all samples, standards, and
controls run in duplicate similar to our methods previously (Pessoa et al., 2019; Kleinstein et al.,
2020) .
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QIIME2 analysis of sequence libraries
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*All Scripts at end of this document. All work was performed on the University of Rhode Island
High Performance Computing Bluewaves cluster:
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https://web.uri.edu/hpc-research-computing/cluster-specifications/
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Data Import

Quality control (QC) steps were conducted according to manufacturer recommendations by
xPONENT 4.2 software (Affymetrix eBioscience, San Diego, USA). Any standards with <70 or
>130 % recovery of beads were invalidated. Samples were required to have a bead count of
>30 beads recovered (all samples had >100 beads recovered and none were excluded at this
step). Following QC, results were reported as average pg/mL for all measured cytokines. The
lower limit of quantification (LLOQ) was determined based on the standard curve (after QC) as
the average value of the lowest validated standards. Values at or below the LLOQ for each
cytokine were reported at the LLOQ. As samples were run in two batches (with similar LLOQs
for each batch), LLOQ for the cytokines (in pg/mL) were averaged across both runs: MIP1α=1.79, IL-1β=5.58, IL-4=23.99, IP-10= 1.17, IL-6=18.89, IL-8=2.48, IL-10=2.01, IL12p70=11.72, IL-13=5.63, IL-17A=4.63, IFN-γ=11.93, GM-CSF=14.57, TNF-α=9.66, MIP1β=7.66, IFN-α=1.32, MCP-1=3.73, P-Selectin=1077.15, IL-1α=0.74, sICAM-1=442.80, and ESelectin=441.00. To compare cytokine levels between study groups, unpaired t-tests were used
with a significance threshold of p<0.05 and no assumption of consistent standard deviation.
Minimum Entropy Decomposition analysis of sequence libraries
Poor quality reads were discarded using flexbar (Dodt et al., 2012). Reads were then treated as
single end reads and trimmed for quality and to a length of 160bp using Trimmomatic (Bolger,
Lohse and Usadel, 2014). Minimum Entropy Decomposition (MED) was performed as described
in the oligotyping pipeline (Eren et al., 2015), generating a list of node representative sequences
and their relative abundances. Taxonomic assignment of representative sequences were
generated based on aligning 16s rRNA sequences at 98.5% identity against the eHOMD
database (Escapa et al., 2018) and further evaluated using the Ribosomal Database Project
(RDP) database (Cole et al., 2014). MED nodes were assigned species level taxonomy based
on >98.5% identity matches to eHOMD and/or RDP with eHOMD designations used as 1 st
priority as our intial aim was to identify oral taxa. Node frequency tables now assigned
taxonomy were then used in association with sample metadata for Linear Discriminate Effect
Size analysis (LEfSe) (Segata et al., 2011).
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Fastq sequence data were imported using the import-fastq.sh script. Generated demux.qzv
files were viewed using https://view.qiime2.org/ via the “quality viewer” function to determine
location for sequence quality trimming used in the following step.
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Fastq Trimming, DADA2 Analysis, Run-run Merging
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A second sequencing run of the prepared Illumina libraries was performed to ensure maximum
sequencing depth without further PCR amplification of starting template. At the end of the “D2merge.sh” script we then used the Rarefaction-alpha.sh script output (Fig. S2) to determine
read depth (22,000) to use in downstream commands.
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Initial Alpha and Beta Diversity Measurements and Run-run Comparison Testing
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Merged libraries were used in the Alpha-Beta-An.sh script to determine initial phylogenetics on
unfiltered data using the QIIME2 core-metrics-phylogenetic function, Alpha and Beta diversity
calculations via QIIME2 alpha- or beta-group-significance functions as well as Beta diversity
difference calculation (beta-group-significance) between sequencing Run 1 vs. Run 2 (Figs. S3,
S4).
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Mock Community Standards Quality Control Testing
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This section uses the mocklibQC1.sh and mocklibQC2.sh scripts. Taxonomy files used are
described below. The *-bar-plots.qzv file generated in the 1st script was viewed at
https://view.qiime2.org/ and the level 6 data from this plot was exported as a .csv file which
provides the reads per each taxa. This data was converted to proportion of total reads per each
taxa and converted into the Zymo_actual.tsv file. The Zymo_expected.tsv file was generated by
editing the Zymo_actual.tsv file with the proportion for each taxa present as provided in the
manufacturers reference:
https://files.zymoresearch.com/protocols/_d6305_d6306_zymobiomics_microbial_community_d
na_standard.pdf
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These .tsv inputs were then used in the mocklibQC2.sh script to output the visualizations seen
in Figure S1.
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Classifier Setup and Editing

257

Initial import of the SILVA 132 classifier was performed by running the following command:
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wget https://data.qiime2.org/2019.7/common/silva-132-99-nb-classifier.qza
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Classifier setup was then performed using the classifier.sh script. Upon searching the silvataxonomy.qzv file generated, we noted that there were no reads that matched A. baumanii
sequences at all. We used the rep-seqs.merge.qzv file output from the D2merge.sh script
saved as a FASTA file from within the QIIME2 viewer function and performed a pairwise blast vs
the full length A. baumanii 16S sequence from NCBI:
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>A.baumanii 16s
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AACGCTGGCGGCAGGCTTAACACATGCAAGTCGAGCGGGGGAAGGTAGCTTGCTACCGG
ACCTAGCGGCGGACGGGTGAGTAATGCTTAGGAATCTGCCTATTAGTGGGGGACAACATC
TCGAAAGGGATGCTAATACCGCATACGTCCTACGGGAGAAAGCAGGGGATCTTCGGACCT
TGCGCTAATAGATGAGCCTAAGTCGGATTAGCTAGTTGGTGGGGTAAAGGCCTACCAAGG
CGACGATCTGTAGCGGGTCTGAGAGGATGATCCGCCACACTGGGACTGAGACACGGCCC

270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289

AGACTCCTACGGGAGGCAGCAGTGGGGAATATTGGACAATGGGGGGAACCCTGATCCAG
CCATGCCGCGTGTGTGAAGAAGGCCTTATGGTTGTAAAGCACTTTAAGCGAGGAGGAGGC
TACTTTAGTTAATACCTAGAGATAGTGGACGTTACTCGCAGAATAAGCACCGGCTAACTCT
GTGCCAGCAGCCGCGGTAATACAGAGGGTGCGAGCGTTAATCGGATTTACTGGGCGTAAA
GCGTGCGTAGGCGGCTTATTAAGTCGGATGTGAAATCCCCGAGCTTAACTTGGGAATTGC
ATTCGATACTGGTGAGCTAGAGTATGGGAGAGGATGGTAGAATTCCAGGTGTAGCGGTGA
AATGCGTAGAGATCTGGAGGAATACCGATGGCGAAGGCAGCCATCTGGCCTAATACTGAC
GCTGAGGTACGAAAGCATGGGGAGCAAACAGGATTAGATACCCTGGTAGTCCATGCCGTA
AACGATGTCTACTAGCCGTTGGGGCCTTTGAGGCTTTAGTGGCGCAGCTAACGCGATAAG
TAGACCGCCTGGGGAGTACGGTCGCAAGACTAAAACTCAAATGAATTGACGGGGGCCCGC
ACAAGCGGTGGAGCATGTGGTTTAATTCGATGCAACGCGAAGAACCTTACCTGGCCTTGA
CATACTAGAAACTTTCCAGAGATGGATTGGTGCCTTCGGGAATCTAGATACAGGTGCTGCA
TGGCTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCT
TTTCCTTACTTGCCAGCATTTCGGATGGGAACTTTAAGGATACTGCCAGTGACAAACTGGA
GGAAGGCGGGGACGACGTCAAGTCATCATGGCCCTTACGGCCAGGGCTACACACGTGCT
ACAATGGTCGGTACAAAGGGTTGCTACACAGCGATGTGATGCTAATCTCAAAAAGCCGATC
GTAGTCCGGATTGGAGTCTGCAACTCGACTCCATGAAGTCGGAATCGCTAGTAATCGCGG
ATCAGAATGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCATGG
GAGTTTGTTGCACCAGAAGTAGCTAGCCTAACTGCAAAGAGGGCGGTTACCACGGTGTGG
CCGATGACTGGGGTGAAGT
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One ASV from the rep-seqs.merge.qzv file (e875355f3179838110485d8f5013d4a6) returned a
100% match homology to the above A. baumanii sequence. This ASV was just annotated as
Acinetobacter in the SILVA-132-99 taxonomy. We then edited the silva classifier taxonomy file
by first exporting it using the following commands:
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module load QIIME2/2019.7

295

qiime tools export \

296

--input-path silva-taxonomy.qza \

297

--output-path silva-taxonomy
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This output the file in *.tsv format which was then opened in a text editor and searched for the
ASV node identity and then modified as indicated here:

300

before

301
302
303

e875355f3179838110485d8f5013d4a6
D_0__Bacteria;D_1__Proteobacteria;D_2__Gammaproteobacteria;D_3__Pseudomonadales;D
_4__Moraxellaceae;D_5__Acinetobacter 0.9999662516375396
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after
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e875355f3179838110485d8f5013d4a6
D_0__Bacteria;D_1__Proteobacteria;D_2__Gammaproteobacteria;D_3__Pseudomonadales;D
_4__Moraxellaceae;D_5__Acinetobacter;D_6__Acinetobacter baumanii
0.9999662516375396
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The edited file was then saved as taxonomy-1.tsv and imported via the following command:

310

qiime tools import \

311

--input-path /data/mramseylab/classifiers/silva-taxonomy/taxonomy-1.tsv \

312

--type 'FeatureData[Taxonomy]' \

313

--input-format TSVTaxonomyFormat \

314

--output-path silva-mod-taxonomy.qza

315

qiime metadata tabulate \

316

--m-input-file silva-mod-taxonomy.qza \

317

--o-visualization silva-mod-taxonomy.qzv

318

The silva-mod-taxonomy.qza file was used for the rest of our analyses.
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Data Filtering
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Data presented throughout the manuscript is generally described as “Minimally Filtered” or
“Strict Filtered”. We 1st began with all ASV assigned data from the above scripts and used
metadata based filtering to separate out all data from control samples which included notemplate and PCR only control indexes. This was done using the control-filter.sh script. Data
output from the script was exported so it could be viewed and then used to subtract taxa from
human-derived datasets in downstream filtering steps. Next we applied the meta-filter.sh script
to our data to extract only human derived samples for further analysis and filtering. After this we
applied the minimal-filter.sh script. Outputs from this script were used in all “Minimally Filtered”
described data in the manuscript. Minimal filtering included removal of instances of taxa that
appeared in only 2 samples or less, features (ASV sequences) that appeared less than 10 times
across all samples and any taxa with less than 20 reads per sample.
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Next we took our output files from the above control-filter.sh script and used them as part of
the input for the auto-filter.sh script to exclude these taxa from the remaining minimally filtered
data. While this removed many spurious taxa from our samples we observed high abundance of
known aquatic microbial contaminant sequences not typically human associated (ex:
Sphingomonas, Ralstonia). These and other taxa were manually excluded using the strictfilter.sh script and further removal of highly abundant Pseudomonas sequences were also
removed via the nopa-filter.sh script. Data filtered to this extent are referred to as “Strictly”
filtered in the manuscript.
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Re-analysis of Filtered Data
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A reanalysis of filtered data was performed 1st for Alpha and Beta diversity measurements via
the alpha-beta2.sh script (Fig. 1). Further description and statistical analysis of Beta diversity
differences were performed in R using the vegan package via the metaMDS and Adonis
functions primarily as demonstrated in the MMR20_ellipses_NMDS.R script below.
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LEfSe Analysis Comparison
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Initial LEfSe analysis was performed using ASV output abundance data directly from the initial
MED pipeline (Fig. 3). Further analysis on QIIME2 / DADA2 assigned strictly filtered data (Fig.
S5) was performed first using the lefse-noTax.sh script to export and format data for analysis
on the LEfSe Galaxy server (https://huttenhower.sph.harvard.edu/galaxy/). This script only
outputs ASV node information without taxonomic assignment. Manual taxonomic assignment
was performed comparing ASV node names to the rep-seqs-merge.qza file from the
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D2merge.sh script. LEfSe analysis was performed using default settings, *.svg output files were
further edited in InkScape software for clarity.
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400

Supplemental Data (Data S1.) Related to Transparent Methods

401

Scripts used for analyses:

402
403

import-fastq.sh

404

module load QIIME2/2019.7

405
406

for d in /data/mramseylab/raw_reads/2018_Serum/Run* ;

407

do

408

SUFX=${d#*Run}

409
410

qiime tools import \

411

--type 'SampleData[PairedEndSequencesWithQuality]' \

412

--input-path /data/mramseylab/raw_reads/2018_Serum/Run$SUFX \

413

--input-format CasavaOneEightSingleLanePerSampleDirFmt \

414
415

--output-path /data/mramseylab/raw_reads/2018_Serum/Run$SUFX/demux$SUFX.qza

416
417

qiime demux summarize \

418
419

--i-data /data/mramseylab/raw_reads/2018_Serum/Run$SUFX/demux$SUFX.qza \

420

--o-visualization /data/mramseylab/visualizations/demux-$SUFX.qzv

421
422
423

done

424

D2merge.sh

425
426

module load QIIME2/2019.7

427
428

for d in /data/mramseylab/raw_reads/2018_Serum/Run* ;

429

do

430

SUFX=${d#*Run}

431
432

qiime dada2 denoise-single \

433
434

--i-demultiplexed-seqs
/data/mramseylab/raw_reads/2018_Serum/Run$SUFX/demux-$SUFX.qza \

435

--p-trim-left 13 \

436

--p-trunc-len 250 \

437
438

--o-table /data/mramseylab/raw_reads/2018_Serum/Run$SUFX/denoisetable-$SUFX.qza \

439
440

--o-representative-sequences
/data/mramseylab/raw_reads/2018_Serum/Run$SUFX/rep-seqs-$SUFX.qza \

441
442
443

--o-denoising-stats
/data/mramseylab/raw_reads/2018_Serum/Run$SUFX/denoising-stats$SUFX.qza

444
445

done

446

#Have to MERGE Run1 and Run2 to get pairwise comparison

447

#Must make directory before running below else it will error out.

448
449

mkdir /data/mramseylab/raw_reads/2018_Serum/Merge_runs/

450
451

qiime feature-table merge \

452
453

--i-tables /data/mramseylab/raw_reads/2018_Serum/Run1/denoise-table1.qza \

454
455

--i-tables /data/mramseylab/raw_reads/2018_Serum/Run2/denoise-table2.qza \

456
457
458

--o-merged-table
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/denoise-tablemerge.qza

459
460

qiime feature-table merge-seqs \

461

--i-data /data/mramseylab/raw_reads/2018_Serum/Run1/rep-seqs-1.qza \

462

--i-data /data/mramseylab/raw_reads/2018_Serum/Run2/rep-seqs-2.qza \

463
464

--o-merged-data
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/rep-seqs-merge.qza

465
466

qiime feature-table summarize \

467
468

--i-table /data/mramseylab/raw_reads/2018_Serum/Merge_runs/denoisetable-merge.qza \

469
470

--o-visualization /data/mramseylab/visualizations/denoise-tablemerge.qzv \

471

--m-sample-metadata-file /data/mramseylab/metadata/Serum5.tsv

472
473

qiime feature-table tabulate-seqs \

474
475

--i-data /data/mramseylab/raw_reads/2018_Serum/Merge_runs/rep-seqsmerge.qza \

476

--o-visualization /data/mramseylab/visualizations/rep-seqs-merge.qzv

477
478

qiime phylogeny align-to-tree-mafft-fasttree \

479
480

--i-sequences /data/mramseylab/raw_reads/2018_Serum/Merge_runs/repseqs-merge.qza \

481
482
483

--o-alignment
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/aligned-rep-seqsmerge.qza \

484
485
486

--o-masked-alignment
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/masked-aligned-repseqs-merge.qza \

487
488

--o-tree /data/mramseylab/raw_reads/2018_Serum/Merge_runs/unrootedtree-merge.qza \

489
490

--o-rooted-tree
/data/mramseylab/raw_reads/2018_Serum/Merge_runs/rooted-tree-merge.qza

491

Rarefaction-alpha.sh

492

module load QIIME2/2019.7

493
494

rawdir=/data/mramseylab/raw_reads/2018_Serum/Merge_runs/

495

procdir=/data/mramseylab/proc_reads/

496

metadir=/data/mramseylab/metadata/

497

visdir=/data/mramseylab/visualizations/

498
499

qiime diversity alpha-rarefaction \

500

--i-table $rawdir\denoise-table-merge.qza \

501

--i-phylogeny $rawdir\rooted-tree-merge.qza \

502

--p-max-depth 25000 \

503

--m-metadata-file $metadir\Serum4.tsv \

504

--o-visualization $visdir\alpha-rarefaction.qzv

505
506
507
508
509
510

511

Alpha-Beta-An.sh

512

module load QIIME2/2019.7

513
514

rawdir=/data/mramseylab/raw_reads/2018_Serum/Merge_runs/

515

procdir=/data/mramseylab/proc_reads/

516

metadir=/data/mramseylab/metadata/

517

cmr="core-metrics-results"

518
519

qiime diversity core-metrics-phylogenetic \

520

--i-phylogeny $rawdir\rooted-tree-merge.qza \

521

--i-table

522

--p-sampling-depth 22000 \

523

--m-metadata-file $metadir\Serum5.tsv \

524

--output-dir $procdir$cmr\-initial

$rawdir\denoise-table-merge.qza \

525
526

qiime diversity alpha-group-significance \

527

--i-alpha-diversity $procdir$cmr\-initial/faith_pd_vector.qza \

528

--m-metadata-file $metadir\Serum5.tsv \

529
530

--o-visualization $procdir$cmr\-initial/faith-pd-groupsignificance.qzv

531
532

qiime diversity alpha-group-significance \

533

--i-alpha-diversity $procdir$cmr\-initial/evenness_vector.qza \

534

--m-metadata-file $metadir\Serum5.tsv \

535
536

--o-visualization $procdir$cmr\-initial/evenness-groupsignificance.qzv

537
538
539
540

array=( unweighted_unifrac_distance_matrix
weighted_unifrac_distance_matrix bray_curtis_distance_matrix )

541

for i in "${array[@]}"

542

do

543
544

qiime diversity beta-group-significance \

545

--i-distance-matrix $procdir$cmr\-initial/$i.qza \

546

--m-metadata-file

547

--m-metadata-column Condition \

548

--o-visualization $procdir$cmr\-initial/$i.qzv \

549

--p-pairwise

$metadir\Serum5.tsv \

550
551

done

552
553

#Generates data for run1 vs run2 variability to measure batch effect

554

qiime diversity beta-group-significance \

555
556

--i-distance-matrix $procdir$cmr\initial/unweighted_unifrac_distance_matrix.qza \

557

--m-metadata-file $metadir\Serum4.tsv \

558

--m-metadata-column Run \

559
560
561
562

--o-visualization $procdir$cmr\-initial/unweighted-unifrac-Runsignificance.qzv \
--p-pairwise

563

Classifier.sh

564

module load QIIME2/2019.7

565
566

rawdir=/data/mramseylab/raw_reads/2018_Serum/Merge_runs/

567

clsdir=/data/mramseylab/classifiers/

568
569

#for the silva release 132 99 .fna file

570
571

qiime feature-classifier classify-sklearn \

572

--i-classifier $clsdir\silva-132-99-nb-classifier.qza \

573

--i-reads $rawdir\rep-seqs-merge.qza \

574

--o-classification $clsdir\silva-taxonomy.qza

575
576
577

#output the taxonomy table to check for A. baumanii strains in it
afterwards.

578
579

qiime metadata tabulate \

580

--m-input-file $clsdir\silva-taxonomy.qza \

581

--o-visualization $clsdir\silva-taxonomy.qzv

582

583

Control-filter.sh

584

module load QIIME2/2019.7

585
586
587

tablein=/data/mramseylab/raw_reads/2018_Serum/Merge_runs/denoisetable-merge.qza

588

clsdir=/data/mramseylab/classifiers/

589

metadir=/data/mramseylab/metadata/

590

visdir=/data/mramseylab/visualizations/

591

filtdir=/data/mramseylab/proc_reads/

592
593

# filter status of input files, "ctrl-filter" is just for taxa
belonging to no template controls

594

fil=ctrl-filter

595
596
597
598

#must make the directory you are filtering to 1st or else it will
error

599

mkdir $filtdir$fil

600
601
602

qiime feature-table filter-samples \

603

--i-table $tablein \

604

--m-metadata-file $metadir\Serum5.tsv \

605

--p-where "[Source]='Control'" \

606

--o-filtered-table $filtdir$fil/$fil-table.qza

607
608

qiime taxa collapse \

609

--i-table $filtdir$fil/$fil-table.qza \

610

--i-taxonomy $clsdir\silva-mod-taxonomy.qza \

611

--p-level 6 \

612

--o-collapsed-table $filtdir$fil/$fil-collapse-table.qza

613
614
615
616
617

qiime feature-table relative-frequency \
--i-table $filtdir$fil/$fil-collapse-table.qza \
--o-relative-frequency-table $filtdir$fil/$fil-relative-collapsetable.qza

618
619

qiime tools export \

620

--input-path $filtdir$fil/$fil-relative-collapse-table.qza \

621

--output-path $filtdir$fil/

622
623

biom convert \

624

-i $filtdir$fil/feature-table.biom \

625

-o $filtdir$fil/$fil-relative-collapse-table.txt \

626

--header-key “taxonomy” \

627

--to-tsv

628
629

#Use above taxa table to filter out based on taxa present in controls

630
631

qiime feature-table filter-features \

632

--i-table $tablein \

633

--m-metadata-file $filtdir$fil/$fil-collapse-table.qza \

634

--o-filtered-table $filtdir$fil/$fil-excluded-table.qza \

635

--p-exclude-ids

636
637

#Use excluded table to generate barplot for checking

638
639

qiime taxa barplot \

640

--i-table $filtdir$fil/$fil-excluded-table.qza \

641

--i-taxonomy $clsdir\silva-mod-taxonomy.qza \

642

--m-metadata-file $metadir\Serum5.tsv \

643

--o-visualization $filtdir$fil/$fil-excluded-table.qzv

644

645

Meta-filter.sh

646

module load QIIME2/2019.7

647
648
649

tablein=/data/mramseylab/raw_reads/2018_Serum/Merge_runs/denoisetable-merge.qza

650

clsdir=/data/mramseylab/classifiers/

651

metadir=/data/mramseylab/metadata/

652

visdir=/data/mramseylab/visualizations/

653

filtdir=/data/mramseylab/proc_reads/

654
655

# filter status of input files, "initial" is the 1st pass no filter at
all

656
657

# "initial-human" is the initial data but for only human samples, no
mock or control samples

658

fil=initial-human

659
660

#note must make directores needed BEFORE running the below command

661

mkdir $filtdir$fil

662
663

qiime feature-table filter-samples \

664

--i-table $tablein \

665

--m-metadata-file $metadir\Serum5.tsv \

666

--p-where "[Source]='Human'" \

667

--o-filtered-table $filtdir$fil/$fil-table.qza

668

669

Auto-filter.sh

670

module load QIIME2/2019.7

671
672

tablein=/data/mramseylab/proc_reads/minF-hum/table3.qza

673

clsdir=/data/mramseylab/classifiers/

674

metadir=/data/mramseylab/metadata/

675

visdir=/data/mramseylab/visualizations/

676

filtdir=/data/mramseylab/proc_reads/

677
678
679

# filter status of input files, "ctrl-filter" is just for taxa
belonging to no template controls

680

fil=AF-hum

681
682

#must make the directory you are filtering to 1st or else it will
error

683

mkdir $filtdir$fil

684
685
686

#Filtering list from mock samples was generated previously with the
control-filter.sh script

687
688
689
690
691

qiime feature-table filter-features \
--i-table $tablein \
--m-metadata-file /data/mramseylab/proc_reads/ctrl-filter/ctrlfilter-collapse-table.qza \

692

--o-filtered-table $filtdir$fil/$fil-excluded-table.qza \

693

--p-exclude-ids

694
695

#Use excluded table to generate barplot for checking

696

qiime taxa barplot \

697

--i-table $filtdir$fil/$fil-excluded-table.qza \

698

--i-taxonomy $clsdir\silva-mod-taxonomy2.qza \

699

--m-metadata-file $metadir\Serum5.tsv \

700

--o-visualization $filtdir$fil/$fil-excluded-table.qzv

701
702
703

#Generate viewable feature table to look for ASVs of interest /
filtering stats

704

qiime feature-table summarize \

705

--i-table $filtdir$fil/$fil-excluded-table.qza \

706

--o-visualization $filtdir$fil/$fil-excluded-table2.qzv \

707

--m-sample-metadata-file $metadir\Serum5.tsv

708

709

Strict-filter.sh

710

module load QIIME2/2019.7

711
712

tablein=/data/mramseylab/proc_reads/AF-hum/AF-hum-excluded-table

713

clsdir=/data/mramseylab/classifiers/

714

metadir=/data/mramseylab/metadata/

715

visdir=/data/mramseylab/visualizations/

716

filtdir=/data/mramseylab/proc_reads/

717
718
719

# filter status of input files, "ctrl-filter" is just for taxa
belonging to no template controls

720

fil=SF-hum

721
722

#must make the directory you are filtering to 1st or else it will
error

723

mkdir $filtdir$fil

724
725
726

#Filtering list from mock samples was generated previously with the
auto-filter.sh script

727
728
729

#Tidying up name here so I can repeatedly use the same input below
through the loop

730

cp $tablein.qza /$filtdir$fil/$fil-table.qza

731

#Array here contains all taxa I wish to remove

732
733
734

array=( Chloroplast Mitochondria Ralstonia Chryseobacterium
Sphingomonas Enhydrobacter Bradyrhizobium Sphingomonadales Rhizobiales
Rhodobacterales Sphingobacteriales Halomonadaceae Deinococcales )

735
736

for i in "${array[@]}"

737

do

738
739

qiime taxa filter-table \

740

--i-table /$filtdir$fil/$fil-table.qza \

741

--i-taxonomy $clsdir\silva-mod-taxonomy2.qza \

742

--p-mode contains \

743

--p-exclude "$i" \

744

--o-filtered-table /$filtdir$fil/$fil-table.qza

745
746

done

747

#Use excluded table to generate barplot for checking

748

qiime taxa barplot \

749

--i-table /$filtdir$fil/$fil-table.qza \

750

--i-taxonomy $clsdir\silva-mod-taxonomy2.qza \

751

--m-metadata-file $metadir\Serum5.tsv \

752

--o-visualization /$filtdir$fil/$fil-table-barplot.qzv

753
754
755

#Generate viewable feature table to look for ASVs of interest /
filtering stats

756

qiime feature-table summarize \

757

--i-table /$filtdir$fil/$fil-table.qza \

758

--o-visualization /$filtdir$fil/$fil-table.qzv \

759

--m-sample-metadata-file $metadir\Serum5.tsv

760

761

Nopa-filter.sh

762

module load QIIME2/2019.7

763
764

tablein=/data/mramseylab/proc_reads/SF-hum/SF-hum-table.qza

765

clsdir=/data/mramseylab/classifiers/

766

metadir=/data/mramseylab/metadata/

767

visdir=/data/mramseylab/visualizations/

768

filtdir=/data/mramseylab/proc_reads/

769
770
771

# filter status of input files, "ctrl-filter" is just for taxa
belonging to no template controls

772

fil=NP-hum

773
774

#must make the directory you are filtering to 1st or else it will
error

775

mkdir $filtdir$fil

776
777
778

#Filtering list from mock samples was generated previously with the
strict-filter.sh script

779
780

qiime taxa filter-table \

781

--i-table $tablein \

782

--i-taxonomy $clsdir\silva-mod-taxonomy2.qza \

783

--p-mode contains \

784

--p-exclude "Pseudomonas" \

785

--o-filtered-table $filtdir$fil/$fil-table.qza

786
787

#Use excluded table to generate barplot for checking

788

qiime taxa barplot \

789

--i-table $filtdir$fil/$fil-table.qza \

790

--i-taxonomy $clsdir\silva-mod-taxonomy2.qza \

791

--m-metadata-file $metadir\Serum5.tsv \

792

--o-visualization $filtdir$fil/$fil-table-barplot.qzv

793
794
795

#Generate viewable feature table to look for ASVs of interest /
filtering stats

796

qiime feature-table summarize \

797

--i-table $filtdir$fil/$fil-table.qza \

798

--o-visualization $filtdir$fil/$fil-table.qzv \

799

--m-sample-metadata-file $metadir\Serum5.tsv

800

801

Alpha-beta2.sh

802

module load QIIME2/2019.7

803
804

rawdir=/data/mramseylab/raw_reads/2018_Serum/Merge_runs/

805

procdir=/data/mramseylab/proc_reads/

806

metadir=/data/mramseylab/metadata/

807

visdir=/data/mramseylab/visualizations/

808

cmr="core-metrics-results"

809
810

# filter status of input files, "initial" is the 1st pass no filter at
all

811

fil=-initial

812
813
814

#note change name of input tables for the 1st command below. Some
input tables did not have standardized filename conventions

815

#changed to AF-hum-table.qza and table3.qza to minF-hum-table.qza

816
817

array=( minF AF SF NP )

818
819

for i in "${array[@]}"

820

do

821
822

qiime diversity core-metrics-phylogenetic \

823

--i-phylogeny $rawdir\rooted-tree-merge.qza \

824

--i-table

825

--p-sampling-depth 5000 \

826

--m-metadata-file $metadir\Serum5.tsv \

827

--output-dir $procdir$i\-hum/$cmr

$procdir$i\-hum/$i\-hum-table.qza \

828
829
830

qiime diversity alpha-group-significance \
--i-alpha-diversity $procdir$i\-hum/$cmr/faith_pd_vector.qza \

831
832
833

--m-metadata-file $metadir\Serum5.tsv \
--o-visualization $procdir$i\-hum/$cmr/faith-pd-groupsignificance.qzv

834
835

qiime diversity alpha-group-significance \

836

--i-alpha-diversity $procdir$i\-hum/$cmr/evenness_vector.qza \

837

--m-metadata-file $metadir\Serum5.tsv \

838
839

--o-visualization $procdir$i\-hum/$cmr/evenness-groupsignificance.qzv

840
841

done

842
843
844
845

#dual array taking the directories above and then running the next
command on the 3 filenames in array2 for each directory prefix in
array 1

846

#note different array command syntax from above vs below

847
848

array1=( minF AF SF NP )

849
850

array2=( unweighted_unifrac_distance_matrix
weighted_unifrac_distance_matrix bray_curtis_distance_matrix )

851

for indirs in ${array1[@]}

852

do

853

for infils in ${array2[@]}

854

do

855
856

qiime diversity beta-group-significance \

857

--i-distance-matrix $procdir$indirs\-hum/$cmr/$infils\.qza \

858

--m-metadata-file $metadir\Serum5.tsv \

859

--m-metadata-column Condition \

860

--o-visualization $procdir$indirs\-hum/$cmr/$infils\.qzv \

861

--p-pairwise

862
863
864

done
done

865

MMR20_ellipses_NMDS.R

866

setwd("E:/2019_Diabetic_Serum/Figure Materials/R-Plots/")

867

library(vegan)

868

library(ggplot2)

869

library(dplyr)

870

set.seed(30)

871
872
873

metadata<-read.csv("Serum5.tsv", header=TRUE, sep="\t",
stringsAsFactors = F)

874
875

featuredf<-read.csv("NP-hum-features.tsv", header=TRUE, sep="\t",
stringsAsFactors = F)

876
877

#making a subset of human only metadata and a few other criteria.

878
879

metadata <- metadata %>% filter(Source == 'Human') %>%
select("sample.id","Condition","Run","Source","ABC")

880
881

#Fixing 1st row to make it row names

882

featuredf <- data.frame(featuredf[,-1], row.names = featuredf[,1])

883
884

#transposing trial1 table to match Evelyns data format

885

featuredf <- as.data.frame(t(featuredf))

886
887

#Brings tables into agreement on matching sample.id values

888

featuredf = featuredf %>% mutate(sample.id = rownames(featuredf))

889
890

#Brings tables into agreement on matching sample.id values

891

table_all = left_join(featuredf, metadata)

892
893
894

#This gets metadata to agree with row numbers of the features table
after splitting out from table_all

895
896

metadata <select(table_all,"sample.id","Condition","Run","Source","ABC")

897
898
899

#filter the "sample.id" column off the very end of the dataframe and
turn it into rownames

900

#NOTE THIS VALUE MUST BE CHANGED FOR EACH INPUT

901
902

featuredf <- data.frame(featuredf[,-1101], row.names =
featuredf[,1101])

903
904
905

# normalize data by sum of ASVs in each sample (this was from ZP's
code)

906

featuredf <- sweep(featuredf,2,colSums(featuredf),`/`)

907
908
909

##Above this was all data input / manipulation, Below this is data
analysis and plotting##

910
911
912

### The function metaMDS is used to calculate the dissimilarity matrix
using the bray curtis distance metrics and at the same

913
914

#time generates the values from the dissimilarity matrix for
ordination plot.

915

MDS <-metaMDS(featuredf ,distance = "bray", k = 3, trymax = 500)

an

916
917
918
919

## Next, extract the x and y coordinates from the MDS plot into a new
data frame and add the metadata factors to the coordinates the data
should be plotted based on.

920
921

#MMR- added ABC=as.factor and changed [,3] to [,5] to agree with my
own metadata file.

922

NMDS_t1=data.frame(NMDS1=MDS$point[,1],NMDS2=MDS$point[,2],

923

Condition=table_all$Condition,ABC=table_all$ABC)

924
925

## set theme for following plots

926

theme_set(theme_bw())

927

928
929

## Generate the ordination based on the solution from above and
selected grouping factor (Condition)

930

plot.new()

931

ord<-ordiellipse(MDS, table_all$Condition,

932
933

= T)

934

dev.off()

display = "sites", kind ="sd", conf = 0.95, label

935
936
937
938

## Data frame df_ell_t1 contains values to show ellipses. It is
calculated with function veganCovEllipse which is hidden in vegan
package.

939
940

#This function is applied to each level of NMDS (group) and it uses
also function cov.wt to calculate covariance matrix.

941
942

veganCovEllipse<-function (cov, center = c(0, 0), scale = 1, npoints =
100)

943

{

944

theta <- (0:npoints) * 2 * pi/npoints

945

Circle <- cbind(cos(theta), sin(theta))

946

t(center + scale * t(Circle %*% chol(cov)))

947

}

948
949

##Generate ellipse points based on 95% confidence (SD) intervals

950
951
952

#Reference : http://stackoverflow.com/questions/13794419/plottingordiellipse-function-from-vegan-package-onto-nmds-plot-created-inggplot

953
954
955
956

#Data frame df_ell contains values to show ellipses. It is calculated
with function veganCovEllipse which is hidden in vegan package. This
function is applied to each level of NMDS (group) and it uses also
function cov.wt to calculate covariance matrix.

957

df_ell_t1 <- data.frame()

958

for(g in levels(NMDS_t1$Condition)){

959

if(g!="" && (g %in% names(ord))){

960
961

df_ell_t1 <- rbind(df_ell_t1,
cbind(as.data.frame(with(NMDS_t1[NMDS_t1$Condition==g,],

962
963
964

veganCovEllipse(ord[[g]]$cov,ord[[g]]$center,ord[[g]]$scale))),Conditi
on=g))}}

965
966

## Calculate p-value:

967
968

adon_t1<-adonis2(featuredf ~Condition, data=metadata,
by=NULL,method="bray", k=3)

969
970

NMDSplot_t1<-ggplot(data=NMDS_t1,aes(NMDS1,NMDS2,col=Condition))+

971

#update from Evelyn to add metadata text to plot if wanted

972
973

#This is useful to identify outlier points if using sample ID text
here, Remove for final plot

974
975

###
geom_text(aes(NMDS1,NMDS2,label=table_all$sample.id),size=2,vjust=0)+

976

# add the p-value in the bottom right corner

977

annotate("text",x=min(NMDS_t1$NMDS1),y=min(NMDS_t1$NMDS2-0.5),

978

label=paste("p= ", adon_t1$`Pr(>F)`[1]),size=3)+

979

# draw the ellipses and define color based on the grouping factor

980
981

geom_path(data=df_ell_t1, aes(x=NMDS1, y=NMDS2, linetype=Condition),
size=1)+

982
983

#scale_linetype_manual(values=c("4-Con"="dotted","3-S4"="solid","2RI-old"="longdash"))+

984
985

#scale_colour_manual(values=c("4-Con"="red", "3-S4"="darkgreen", "2RI-old"="purple"))+

986

# add the points per sample and define shape based on TankLocation

987

geom_point(aes(shape=ABC), size=2) +

988

# Reorder the legend

989

guides(color = guide_legend(order=1),lty= guide_legend(order=1),

990

shape = guide_legend(order=2), legend.position = "bottom")

991
992

# Adding other Aethestics

993
994
995

NMDS_by_Trial1 <- NMDSplot_t1 + theme(axis.text.y =
element_text(size="12", color="black"), axis.title.y =
element_text(face="bold",size="12", color="black"))+

996
997
998

theme(axis.text.x = element_text(size="12", color="black"),
axis.title.x.bottom = element_text(face="bold",size="12",
color="black"))+

999
1000

theme(axis.text.x.top= element_text(face="bold",size="12",
color="black")) +

1001

#change name of the legend

1002

theme(legend.title=element_blank())+

1003
1004

theme(legend.position = "right", legend.title =
element_text(colour="black", size=16, face="bold"))

1005
1006
1007

print(NMDS_by_Trial1)

1008

print(NMDSplot_t1)

1009

1010

Lefse-noTax.sh

1011

module load QIIME2/2019.7

1012
1013

clsdir=/data/mramseylab/classifiers/

1014

metadir=/data/mramseylab/metadata/

1015

visdir=/data/mramseylab/visualizations/

1016

filtdir=/data/mramseylab/proc_reads/

1017

rawdir=/data/mramseylab/raw_reads/2018_Serum/Merge_runs/

1018

procdir=/data/mramseylab/proc_reads/

1019
1020

array=( minF-hum AF-hum SF-hum NP-hum )

1021
1022

for i in "${array[@]}"

1023

do

1024
1025

qiime feature-table relative-frequency \

1026

--i-table $filtdir$i/$i\-table.qza \

1027

--o-relative-frequency-table $filtdir$i/$i\-table.notax.qza

1028
1029

qiime tools export \

1030

--input-path $filtdir$i/$i\-table.notax.qza \

1031

--output-path $filtdir$i/

1032
1033

#note, must use single hashes for -i / -o unlike other qiime commands.

1034

biom convert \

1035

-i $filtdir$i/feature-table.biom \

1036

-o $filtdir$i/$i\-notax.table.txt \

1037

--header-key “taxonomy” \

1038

--to-tsv

1039
1040
1041
1042

done

